Citation: Nc. Long et al., Ozone causes lipid peroxidation but little antioxidant depletion in exercising and nonexercising hamsters, J APP PHYSL, 91(4), 2001, pp. 1694-1700
Authors:
Dworski, R
Roberts, LJ
Murray, JJ
Morrow, JD
Hartert, TV
Sheller, JR
Citation: R. Dworski et al., Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F-2-isoprostane, 15-F-2t-IsoP (8-iso-PGF(2 alpha)), CLIN EXP AL, 31(3), 2001, pp. 387-390
Authors:
Suh, JH
Shigeno, ET
Morrow, JD
Cox, B
Rocha, AE
Frei, B
Hagen, TM
Citation: Jh. Suh et al., Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-alpha-lipoic acid, FASEB J, 15(3), 2001, pp. 700-706
Citation: Ee. Reich et al., Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice, J NEUROSC, 21(16), 2001, pp. 5993-5999
Citation: Ds. Vanderende et Jd. Morrow, Release of markedly increased quantities of prostaglandin D-2 from the skin in vivo in humans after the application of cinnamic aldehyde, J AM ACAD D, 45(1), 2001, pp. 62-67
Authors:
Marathe, GK
Harrison, KA
Roberts, LJ
Morrow, JD
Murphy, RC
Tjoelker, LW
Prescott, SM
Zimmerman, GA
McIntyre, TM
Citation: Gk. Marathe et al., Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver, J LIPID RES, 42(4), 2001, pp. 587-596
Citation: Jd. Morrow, Competition and cooperation: Conversations with nobelists about economics and political science., J ECON LIT, 39(2), 2001, pp. 567-569
Authors:
Kozak, KR
Crews, BC
Ray, JL
Tai, HH
Morrow, JD
Marnett, LJ
Citation: Kr. Kozak et al., Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo, J BIOL CHEM, 276(40), 2001, pp. 36993-36998
Citation: Im. Robbins et al., Increased levels of prostaglandin D-2 suggest macrophage activation in patients with primary pulmonary hypertension, CHEST, 120(5), 2001, pp. 1639-1644
Authors:
Montine, TJ
Kaye, JA
Montine, KS
McFarland, L
Morrow, JD
Quinn, JF
Citation: Tj. Montine et al., Cerebrospinal fluid A beta(42), tau, and F-2-isoprostane concentrations inpatients with Alzheimer disease, other dementias, and in age-matched controls, ARCH PATH L, 125(4), 2001, pp. 510-512
Citation: Lj. Murphey et al., Quantification of BK1-5, the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay, ANALYT BIOC, 292(1), 2001, pp. 87-93
Citation: Ee. Reich et al., Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, AM J PATH, 158(1), 2001, pp. 293-297
Authors:
Suman, OE
Morrow, JD
O'Malley, KA
Beck, KC
Citation: Oe. Suman et al., Airway function after cyclooxygenase inhibition during hyperpnea-induced bronchoconstriction in guinea pigs, J APP PHYSL, 89(5), 2000, pp. 1971-1978
Authors:
Ames, PRJ
Tommasino, C
Alves, J
Morrow, JD
Iannaccone, L
Fossati, G
Caruso, S
Caccavo, F
Brancaccio, V
Citation: Prj. Ames et al., Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study, LUPUS, 9(9), 2000, pp. 688-695
Citation: Tj. Montine et al., No difference in plasma or urinary F-2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls, ANN NEUROL, 48(6), 2000, pp. 950-950
Authors:
Chen, K
Suh, J
Carr, AC
Morrow, JD
Zeind, J
Frei, B
Citation: K. Chen et al., Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload, AM J P-ENDO, 279(6), 2000, pp. E1406-E1412